Literature DB >> 1633609

The effects of Ca2+ and calmodulin on adenylyl cyclase activity in plasma membranes derived from neural and non-neural cells.

K K Caldwell1, C L Boyajian, D M Cooper.   

Abstract

The regulation of adenylyl cyclase activity by varying concentrations of Ca2+ was examined in plasma membrane preparations derived from a number of neural and non-neural cells. Enzyme activity in neural tissue (i.e. cerebellum) neural-derived pheochromocytoma PC12 cells and certain endocrine cells (i.e. pancreatic RINm5f and parathyroid cells) was stimulated by physiologic concentrations of Ca2+ by a calmodulin (CaM)-dependent mechanism. In contrast, adenylyl cyclase activity in non-neural cells (e.g. platelets and GH3 cells) was not stimulated by Ca2+. In these latter sources, enzyme activity was inhibited by increasing concentrations of Ca2+, independent of CaM. In liver membranes, Ca2+ and/or CaM did not alter adenylyl cyclase activity. These results demonstrate that the effects exerted by physiologic concentrations of Ca2+ on adenylyl cyclase activity range from CaM-dependent stimulation of activity to no effect, to CaM-independent inhibition of activity. The actions of Ca2+ on adenylyl cyclase may be major contributors to the various synergistic or antagonistic interactions that are seen between cAMP-generating and Ca(2+)-mobilizing systems.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1633609     DOI: 10.1016/0143-4160(92)90004-c

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  11 in total

Review 1.  Regulation and organization of adenylyl cyclases and cAMP.

Authors:  Dermot M F Cooper
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

2.  Expression of a neuronal nicotinic acetylcholine receptor in insect and mammalian host cell systems.

Authors:  E M Aztiria; M C Sogayar; F J Barrantes
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

3.  Role and mechanisms of action of acetylcholine in the regulation of rat cholangiocyte secretory functions.

Authors:  D Alvaro; G Alpini; A M Jezequel; C Bassotti; C Francia; F Fraioli; R Romeo; L Marucci; G Le Sage; S S Glaser; A Benedetti
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

4.  Predominant expression of type-VI adenylate cyclase in C6-2B rat glioma cells may account for inhibition of cyclic AMP accumulation by calcium.

Authors:  M A Debernardi; R Munshi; M Yoshimura; D M Cooper; G Brooker
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

5.  Ca(2+)-inhibitable adenylyl cyclase modulates pulmonary artery endothelial cell cAMP content and barrier function.

Authors:  T Stevens; Y Nakahashi; D N Cornfield; I F McMurtry; D M Cooper; D M Rodman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  Cloning and expression of a Ca(2+)-inhibitable adenylyl cyclase from NCB-20 cells.

Authors:  M Yoshimura; D M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

7.  Ca(2+)-dependent and -independent mechanism of cyclic-AMP reduction: mediation by bradykinin B2 receptors.

Authors:  H Sipma; A den Hertog; A Nelemans
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

8.  A role for cAMP in angiotensin II mediated inhibition of cell growth in AT1A receptor-transfected CHO-K1 cells.

Authors:  T J Thekkumkara; J Du; C Zwaagstra; K M Conrad; J Krupinski; K M Baker
Journal:  Mol Cell Biochem       Date:  1995-11-08       Impact factor: 3.396

9.  Structural basis for inhibition of mammalian adenylyl cyclase by calcium.

Authors:  Tung-Chung Mou; Nanako Masada; Dermot M F Cooper; Stephen R Sprang
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

10.  Dominant regulation of interendothelial cell gap formation by calcium-inhibited type 6 adenylyl cyclase.

Authors:  Donna L Cioffi; Timothy M Moore; Jerry Schaack; Judy R Creighton; Dermot M F Cooper; Troy Stevens
Journal:  J Cell Biol       Date:  2002-06-24       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.